Functional analysis in human gliomas suggested that HOXD9 deletion induced apoptosis via downregulation of anti-apoptotic factor B-cell lymphoma-2 (BCL-2) and upregulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) [8]. Here, HOXD9 is linked to central nervous system cancer.